Scroll Back to Top

 

Thank you for joining us at AACR Annual Meeting 2023
April 14 – 19 | Orlando, FL | Booth #2442

Thank you for joining us at AACR Annual Meeting 2023 in Orlando, Florida.  It was a pleasure to meet with everyone who came to visit us at our booth.  If you did not get a chance to meet with us, or have a question and would like someone to contact you, please click on the button below.  

  • VIEW OUR POSTERS 
     

    Session Category: Tumor Biology

    #37   A novel technique to preclinically assess the ability of targeted therapies to inhibit both primary and metastatic non-small cell lung carcinoma 
    Erin Trachet
    Session Category: Tumor Biology 
    Session Title: Novel Models of Human Cancer 
    View poster

    #41   Growth kinetics and immune cell profiling of BT-474 human breast carcinoma and Raji-Luc human Burkitt lymphoma in triple immunodeficient mice 
    Justin Snider 
    Session Category: Tumor Biology 
    Session Title: Novel Models of Human Cancer 
    View poster

    #2402   Fractionated dosing: A more clinically relevant approach to radiotherapy in preclinical tumor models 
    Kerry Ann Bright 
    Session Category: Tumor Biology 
    Session Title: Radiation Sciences 
    View poster
     

    #4654   Differential immunomodulation following checkpoint blockade in the orthotopic ID8-luc ovarian model 
    Sheri Barnes 
    Session Category: Tumor Biology 
    Session Title: Inflammation and Tumor Progression 
    View poster

    #4561   3D Reconstructed Pancreas: A model capturing the unique tumor microenvironment and stromal architecture of pancreatic cancer 
    Dr. Uihlein (Predictive Oncology) 
    Session Category: Tumor Biology 
    Session Title: 3D and Tissue Recombinant Models 
    View poster

    #5945   Transcriptional analysis of TME in MC38 colon carcinoma model following checkpoint inhibition 
    Priyanka Singh 
    Session Category: Tumor Biology 
    Session Title: Tumor-Stromal Cell (Including Immune Cell) Interactions and Therapy Responses 
    View poster

    Session Category: Experimental and Molecular Therapeutics 

    #589   Long-term acclimation of target cell lines to tumor microenvironment culture condition provides mechanistic insights into cell therapy effectiveness 
    James Lim (Xcell Bio)
    Session Category: Experimental and Molecular Therapeutics 
    Session Title: Targeting the Tumor Microenvironment 


    #2749   Preclinical assessment of chimeric antigen receptor (CAR) T persistence and functionality in the disseminated NALM6-Luc human B cell acute lymphoblastic leukemia (ALL) model 
    Dave Draper 
    Session Category: Experimental and Molecular Therapeutics 
    Session Title: Innovative Assay Technologies 
    View poster

    #2762    Inhibition of Murine Myeloid Suppressor Cells Increases CD8+ T cell Activation in Vitro 
    Anita Zaitouna 
    Session Category: Experimental and Molecular Therapeutics 
    Session Title: Innovative Assay Technologies 
    View poster

    Session Category: Immunology

    #1782   Functional potency assay predicts CAR-T effectiveness in tumor microenvironment 
    Yelena Bronevetsky (Xcell Bio) 
    Session Category: Immunology 
    Session Title: CAR T-cell Therapy 
     

    Session Category: Clinical Research Excluding Trials

    #3358   Prognostic value of post surgery liquid biopsy cell free circulating tumor DNA in stage III colon cancer patients PLCRC PROVENC3 study
    Carmen Rubio Alarcón
    Session Category: Clinical Research Excluding Trials
    Session Title: PO.CL01.16 - Liquid Biopsies: Circulating Nucleic Acids and Circulating Tumor Cells 3
    View poster

     
    #5452   Complimentary use of DNA- and RNA-based NGS assays optimizes detection of clinically relevant translocations for comprehensive genomic profiling

    Rongqin Ren
    Session Category: Clinical Research Excluding Trials
    Session Title: Biomarkers of Therapeutic Benefit 5
    View poster

    #5587   Ultra-deep targeted sequencing of cell-free DNA and patient-matched white blood cells for treatment response evaluation in patients with metastatic colorectal cancer.
    Iris van ‘t Erve
    Session Category: Clinical Research Excluding Trials
    Session Title: PO.CL01.17 - Liquid Biopsies: Circulating Nucleic Acids and Circulating Tumor Cells 4
    View poster


    #5597   Enhanced detection and classification of cell-free DNA alterations through matched normal analyses with PGDx elio plasma complete
    Tonya N. Watkins
    Session Category: Clinical Research Excluding Trials
    Session Title: PO.CL01.17 - Liquid Biopsies: Circulating Nucleic Acids and Circulating Tumor Cells 4
    View poster

    #923   Genomic landscape of patients with non-small cell lung cancer
    Neeraj Kumar Singh
    Session Category: Clinical Research Excluding Trials    
    Session Title: PO.CL11.01 - Analyses Using Clinical and Genomic Databases
    View poster

    Session Category: Experimental and Molecular Therapeutics  

    #6220   Development of a mutation profiling NGS assay to facilitate clinical decisions in hematologic malignancies.
    Grant Hogg
    Session Category: Experimental and Molecular Therapeutics        
    Session Title: DNA Repair / Molecular Classification of Tumors for Diagnostics, Prognostics, and Therapeutic Outcomes / Others
    View poster

    Session Category: Clinical Trials  

    #CT212   A ctDNA-directed, multi-center phase II study of molecular response adaptive immuno-chemotherapy in patients with non-small cell lung cancer: Analysis of Stage 1 of CCTG BR.36
    Valsamo Anagnostou
    Session Category: Clinical Trials    
    Session Title: PO.CT02.02 - Phase II Clinical Trials 2
    View poster
     

Get Email Updates

Stay current by signing up to receive the latest news and updates on tests and services.